[CLSTR]
< Back to situations

[ORGANIZATION]

EMA

Featured in 15 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [IT]

Italy influenza, COVID-19 and RSV vaccination rollout

22 clusters · 203 sources · last updated

Latest: Italy launches regional vaccination campaigns in Marche and Molise

The 2026-2027 seasonal vaccination campaign in Italy, targeting influenza, COVID-19, and Respiratory Syncytial Virus (RSV), is underway following preparations in September. Ahead of the October rollout, the Italian Medic

[ACTIVE] [HEALTH] [MX]

Mexico public health and vaccination initiatives

9 clusters · 80 sources · last updated

Latest: Mexico launches national winter vaccination campaign

The Mexican government is executing a broad public health strategy focused on vaccination campaigns and infrastructure expansion. For the 2026-2027 winter season, the administration is utilizing Pfizer and Moderna vaccin

[ACTIVE] [HEALTH] [CL] [US]

Ozempic medical uses and reported effects

3 clusters · 6 sources · last updated

Latest: Monserrat Álvarez reports adverse side effects from Ozempic use

Ozempic, a medication approved by the FDA and EMA for treating type 2 diabetes, is increasingly utilized for weight management through off-label prescriptions. Users have reported significant weight reduction and improve

[QUIET] [HEALTH] [US] [IT] [GR]

FDA approves Rasonque; EMA recommends for pancreatic cancer

44 clusters · 321 sources · last updated

Latest: Pancreatic cancer: New research and treatment developments in Greece

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R

[QUIET] [INTERNATIONAL] [ES] [AR]

Severe weather and DANA Adam impact in Spain

2 clusters · 98 sources · last updated

Latest: Spain and Argentina face extreme weather as storms and temperature shifts hit

As of October 16, the weather situation has intensified with the arrival of ‘Adam’, the first high-impact DANA (isolated high-altitude depression) of the 2026-2027 season, as identified by the State Meteorological Agency

[QUIET] [BUSINESS] [US] [EU] [CN]

AstraZeneca regulatory and portfolio developments

3 clusters · 5 sources · last updated

Latest: AstraZeneca and Johnson & Johnson advance new cancer treatments

AstraZeneca has achieved several regulatory milestones regarding its oncology and rare disease pipelines. In Europe, the company received approval for Enhertu in combination with pertuzumab for first-line treatment of HE

Also covered in